Nataly
Nataly Boulatnikov, Rochester, NY US
Patent application number | Description | Published |
---|---|---|
20090035470 | PNEUMATICALLY ADJUSTABLE APPARATUS FOR COATING TONER FUSING BELT SUBSTRATE AND METHOD FOR USING SAME - An apparatus for enabling the uniform application of a layer of a coating composition to a tubular substrate includes a shaft, and upper and lower circular rim members of equal diameter that are concentrically attached to the shaft. A pneumatically inflatable tube disposed on each circular rim member has an outer diameter that is variable with changes in its internal pressure. A first flexible cylindrical sheet in contact with the inflatable tubes has parallel edges that form a first slit sufficiently wide to permit movement of the first sheet in response to pressure variation in the tubes. A second flexible cylindrical sheet surrounding the first cylindrical sheet has parallel edges that form a second slit sufficiently wide to permit movement of the second sheet also in response to pressure variation. The second slit is laterally displaced from the first slit, and the second cylindrical sheet has a diameter nearly equal to the specified diameter of the substrate. Each of the tubes is inflatable to a pressure sufficient to provide the substrate with a smooth cylindrical outer surface for uniform application of a coating. | 02-05-2009 |
20110159222 | FLUOROCARBON THERMOPLASTIC MATERIALS CURED WITH ORGANIC PRIMARY AMINES - A composition comprising a fluorocarbon thermoplastic random copolymer having the subunits of: | 06-30-2011 |
Nataly Fetissova, Moscow RU
Patent application number | Description | Published |
---|---|---|
20130266521 | Oral Compositions Comprising Propolis - Oral compositions are provided that comprise a propolis extract; an oral care active compound chosen from: a cationic antibacterial agent, an anti-attachment agent, a biofilm disruption agent, and an anti-inflammatory agent; and a source of fluoride ions. Further, in certain embodiments, the oral composition comprises an anionic polymeric linear polycarboxylate. The oral composition can be in a form of a mouth rinse, a dentifrice, a confectionary, a medicament, or a film. Methods of making and using the oral compositions are also provided. | 10-10-2013 |
20150044266 | Oral Compositions Comprising Propolis - Oral compositions are provided that comprise a propolis extract; a halogenated diphenyl ether non-ionic antibacterial agent; an anionic polymeric copolymer of methyl vinyl ether and maleic anhydride; and a source of fluoride ions. The oral composition can be in a form of a mouth rinse, a dentifrice, a confectionary, a medicament, or a film. Methods of making and using the oral compositions are also provided. | 02-12-2015 |
Nataly Pogrebinsky, Sammamish, WA US
Patent application number | Description | Published |
---|---|---|
20130346241 | INFRASTRUCTURE SUPPORTING A DISTRIBUTED APPROVAL WORKFLOW - The validation of a product for placement in a catalog in a marketplace utilizes a distributed approval workflow. A validation engine receives product submissions for inclusion into the marketplace's catalog. The validation engine initiates the distributed approval workflow to one or more approval engines that are equipped to perform the tasks needed to validate the product. The validation engine monitors the distributed approval workflow performed by the approval engines until completion. Upon successful completion of the distributed approval workflow, the product may be placed onto the marketplace's catalog for distribution. | 12-26-2013 |
Nataly Shtraizent, New York, NY US
Patent application number | Description | Published |
---|---|---|
20080199450 | ACID CERAMIDASE AND CELL SURVIVAL - The present invention relates to methods of promoting the survival of cells by treating the cells with acid ceramidase. A kit for promoting ex vivo cell survival is also disclosed, as is a method of predicting in vitro fertilization outcome of a female subject. | 08-21-2008 |
Nataly Urshanski, Rehovot IL
Patent application number | Description | Published |
---|---|---|
20150139983 | USE OF BLOCKING AGENTS OF BONE MORPHOGENIC PROTEIN (BMP) SIGNALLING FOR THE TREATMENT OF NEUROINFLAMMATORY AND NEURODEGENERATIVE DISEASES - The invention provides pharmaceutical compositions for the treatment of neuroinflammatory or neurodegenerative diseases comprising a single or a combination of several blocking agent(s) of Bone Morphogenic Protein (BMP) signaling. The invention further provides methods of treatment of neuroinflammatory or neurodegenerative diseases comprising administering to a patient in need thereof the pharmaceutical compositions of the invention. | 05-21-2015 |
Nataly Vinikur, Nahariya IL
Patent application number | Description | Published |
---|---|---|
20090217411 | SALT RESPONSIVE GENES USEFUL FOR GENERATING SALT RESISTANT TRANSGENIC PLANTS - The present invention relates to a transgenic plant comprising one or more plant cells transformed with exogenous nucleic acid encoding a | 08-27-2009 |
Nataly Wieberneit, Hamburg DE
Patent application number | Description | Published |
---|---|---|
20140328458 | INDIVIDUAL MONITORING OF COMPRESSION FOR MAMMOGRAPHIC EXAMINATIONS - The present invention relates to mammography. In particular, the present invention relates to a method and a corresponding system for individually monitoring a compression force in an apparatus for mammographic examination for personalized compression guidance. In order to provide a personalized guidance for the compression of the breast in a first step (S | 11-06-2014 |
Nataly Zissman, Nesher IL
Patent application number | Description | Published |
---|---|---|
20090143360 | Oxcarbazepine Formulation - The present invention relates to novel uncoated, color-stable tablet formulations comprising oxcarbazepine, a disintegrant and iron oxide pigments. The oxcarbazepine of the present invention has a particle size of about 14 to about 30 microns with a maximum residue on a 40 micron sieve from about 10% to about 35%. The present invention further provides for a process of preparing the tablet formulations, and a method of treating mammals in need of oxcarbazepine with the novel formulation. | 06-04-2009 |
20130017254 | PHARMACEUTICAL FORMULATION CONTAINING PHENYTOIN SODIUM AND MAGNESIUM STEARATE - The present invention relates to a novel pharmaceutical formulation comprising phenytoin sodium, a high amount of magnesium stearate, and a low level of a hydrophilic polymer such as a methocel, and a method of preparing the same by blending. | 01-17-2013 |